WilliamL. Heyward

594 total citations
8 papers, 439 citations indexed

About

WilliamL. Heyward is a scholar working on Epidemiology, Hepatology and Virology. According to data from OpenAlex, WilliamL. Heyward has authored 8 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Hepatology and 2 papers in Virology. Recurrent topics in WilliamL. Heyward's work include Hepatitis B Virus Studies (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (3 papers). WilliamL. Heyward is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (3 papers). WilliamL. Heyward collaborates with scholars based in United States, Democratic Republic of the Congo and India. WilliamL. Heyward's co-authors include B. J. McMahon, D. P. Francis, Thomas R. Bender, D. B. Hall, Wallace L.M. Alward, J. E. Maynard, Donald G. Ritter, Jeffrey E. Harris, Freya Spielberg and K. Odehouri and has published in prestigious journals such as The Lancet, JAMA and The Journal of Infectious Diseases.

In The Last Decade

WilliamL. Heyward

8 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
WilliamL. Heyward United States 7 328 260 87 50 29 8 439
R Williams United States 9 190 0.6× 109 0.4× 138 1.6× 103 2.1× 28 1.0× 17 378
Kenneth R. Berquist United States 8 263 0.8× 191 0.7× 78 0.9× 11 0.2× 25 0.9× 12 348
Rudolf A. Heijtink Netherlands 17 655 2.0× 568 2.2× 148 1.7× 26 0.5× 33 1.1× 23 743
A Milne United States 13 280 0.9× 199 0.8× 39 0.4× 17 0.3× 73 2.5× 27 410
Cheng‐Hsiung Roan Taiwan 6 596 1.8× 480 1.8× 110 1.3× 22 0.4× 119 4.1× 6 697
I. K. Kuramoto United States 11 323 1.0× 448 1.7× 171 2.0× 20 0.4× 8 0.3× 20 525
A. Roumeliotou‐Karayannis Greece 14 573 1.7× 511 2.0× 99 1.1× 11 0.2× 49 1.7× 31 667
Carolyn Campbell United States 9 498 1.5× 448 1.7× 59 0.7× 23 0.5× 8 0.3× 11 532
A Leentvaar-Kuypers Netherlands 6 742 2.3× 796 3.1× 101 1.2× 32 0.6× 27 0.9× 8 896
Selokela G. Selabe South Africa 12 378 1.2× 315 1.2× 138 1.6× 54 1.1× 13 0.4× 37 439

Countries citing papers authored by WilliamL. Heyward

Since Specialization
Citations

This map shows the geographic impact of WilliamL. Heyward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WilliamL. Heyward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WilliamL. Heyward more than expected).

Fields of papers citing papers by WilliamL. Heyward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WilliamL. Heyward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WilliamL. Heyward. The network helps show where WilliamL. Heyward may publish in the future.

Co-authorship network of co-authors of WilliamL. Heyward

This figure shows the co-authorship network connecting the top 25 collaborators of WilliamL. Heyward. A scholar is included among the top collaborators of WilliamL. Heyward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WilliamL. Heyward. WilliamL. Heyward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Spielberg, Freya, et al.. (1989). FIELD TESTING AND COMPARATIVE EVALUATION OF RAPID, VISUALLY READ SCREENING ASSAYS FOR ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS. The Lancet. 333(8638). 580–584. 64 indexed citations
2.
Odehouri, K., et al.. (1989). RAPID EMERGENCE OF AIDS IN ABIDJAN, IVORY COAST. The Lancet. 334(8660). 408–411. 42 indexed citations
3.
McMahon, B. J., et al.. (1987). A COMPREHENSIVE PROGRAMME TO REDUCE THE INCIDENCE OF HEPATITIS B VIRUS INFECTION AND ITS SEQUELAE IN ALASKAN NATIVES. The Lancet. 330(8568). 1134–1136. 87 indexed citations
4.
Alward, Wallace L.M., B. J. McMahon, D. B. Hall, et al.. (1985). The Long-Term Serological Course of Asymptomatic Hepatitis B Virus Carriers and the Development of Primary Hepatocellular Carcinoma. The Journal of Infectious Diseases. 151(4). 604–609. 155 indexed citations
6.
Heyward, WilliamL., et al.. (1983). EARLY DETECTION OF PRIMARY HEPATOCELLULAR CARCINOMA BY SCREENING FOR ALPHA-FETOPROTEIN IN HIGH-RISK FAMILIES. The Lancet. 322(8360). 1161–1162. 28 indexed citations
7.
Heyward, WilliamL., et al.. (1982). SEROLOGICAL MARKERS OF HEPATITIS B VIRUS AND ALPHA-FETOPROTEIN LEVELS PRECEDING PRIMARY HEPATOCELLULAR CARCINOMA IN ALASKAN ESKIMOS. The Lancet. 320(8304). 889–891. 52 indexed citations
8.
McMahon, Brian J., WilliamL. Heyward, Thomas R. Bender, et al.. (1980). A Prospective Study of Hepatitis B Virus Serologic Markers and Liver Enzymes. The Journal of Infectious Diseases. 142(5). 772–772. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026